Investors

Press Releases

Endonovo Therapeutics Announces Receipt of Notice of Allowance from the United States Patent and Trademark Office
Endonovo Expands SofPulse Commercialization
Endonovo Therapeutics Announces Strategic Relationship with US Authentic Trading Company
Endonovo Therapeutics Announces Complimentary New Product
Endonovo Therapeutics Provides Update on Liver Study
Endonovo Therapeutics Signs Distribution Agreement For National Distribution of Sofpulse® Electroceutical™ System
Endonovo Therapeutics Announces Enrollment of First Patient in Clinical Study at the University of New Mexico for Treating Traumatic Brain Injury Using Its Electroceutical™ Therapy
Endonovo Therapeutics Signs Distribution Agreement with Plagens Medical Consultants for its Pain Relief Electroceutical™ SofPulse®
Endonovo Therapeutics Highlights Feasibility Study Results of Its Electroceutical Therapy in Reducing Proteinuria in Chronic Kidney Disease Patients
Endonovo Therapeutics Inc. to Move Forward with a Clinical Research Study Conducted by the Regents of the University of New Mexico
RSS
Show All